Eprontia (topiramate) oral solution, 25 mg/mL, 473 mL Bottle, Rx only, Manufactured for: Azurity Pharmaceuticals, Woburn, MA 01801, NDC 52652-9001-1
Class I - DangerousWhat Should You Do?
- Check if you have this product: Lot #: MB22020B, Exp 12/27/2023
- Do not eat it: Even if it looks and smells fine, do not consume this product.
- Throw it away or return it: You can return the product to the store for a full refund.
- Seek medical attention if needed: If you've consumed this product and feel unwell, contact your doctor immediately.
- Report problems: Report any issues to the FDA's Safety Reporting Portal.
⚠️ Emergency: If you experience severe symptoms after consuming this product, call 911 or Poison Control at 1-800-222-1222.
Recall Details
- Company:
- Azurity Pharmaceuticals, Inc.
- Reason for Recall:
- Failed Impurities/Degradation Specifications: Out of specification Impurity C (4,5-desisopropylidene topiramate) result observed during routine stability testing at 18 months.
- Classification:
- Class I - Dangerous
Dangerous or defective products that predictably could cause serious health problems or death.
- Status:
- terminated
Product Information
Full Description:
Eprontia (topiramate) oral solution, 25 mg/mL, 473 mL Bottle, Rx only, Manufactured for: Azurity Pharmaceuticals, Woburn, MA 01801, NDC 52652-9001-1
Product Codes/Lot Numbers:
Lot #: MB22020B, Exp 12/27/2023
Official Source
Always verify recall information with the official FDA source:
View on FDA.govFDA Recall Number: D-0213-2024
Related Recalls
Zenzedi (Dextroamphetamine Sulfate) CII Tablets, USP, 30 mg, 30-count bottle, Rx only, Mfd. for: Arbor Pharmaceuticals, LLC., Atlanta, Georgia, 30328, NDC 24338-856-03
Azurity Pharmaceuticals
Class I - Dangerous
Labeling: Label Mix-up
Class I - Dangerous
cGMP: complaints of crystals not redissolving into solution after warming and shaking the vials.
Class I - Dangerous
Product Mix-up: Incorrect diluent component included in the kit.